Your browser doesn't support javascript.
loading
Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party.
Schetelig, Johannes; Chevallier, Patrice; van Gelder, Michel; Hoek, Jennifer; Hermine, Olivier; Chakraverty, Ronjon; Browne, Paul; Milpied, Noel; Malagola, Michele; Socié, Gerard; Delgado, Julio; Deconinck, Eric; Damaj, Ghandi; Maury, Sebastian; Beelen, Dietrich; Quoc, Stéphanie Nguyen; Shankara, Paneesha; Brecht, Arne; Mayer, Jiri; Hunault-Berger, Mathilde; Bittenbring, Jörg; Thieblemont, Catherine; Lepretre, Stéphane; Baldauf, Henning; de Wreede, Liesbeth C; Tournilhac, Olivier; Yakoub-Agha, Ibrahim; Kröger, Nicolaus; Dreger, Peter.
Afiliação
  • Schetelig J; Medical Clinic I, University Hospital, Dresden, Germany. johannes.schetelig@uniklinikum-dresden.de.
  • Chevallier P; DKMS, Dresden, Germany. johannes.schetelig@uniklinikum-dresden.de.
  • van Gelder M; CHU Nantes, Nantes, France.
  • Hoek J; University Hospital Maastricht, Maastricht, The Netherlands.
  • Hermine O; EBMT Data Office, Leiden, The Netherlands.
  • Chakraverty R; Department of Hematology, Necker Hospital and INSERM U1163 Imagine Institute, University of Paris, Paris, France.
  • Browne P; Cancer Institute and Institute of Immunity and Transplantation, University College London Hospital, London, UK.
  • Milpied N; Hope Directorate, Dublin, Ireland.
  • Malagola M; CHU Bordeaux, Pessac, France.
  • Socié G; Bone Marrow Transplant Unit, ASST-Spedali Civili di Brescia, University of Brescia, Brescia, Italy.
  • Delgado J; Hopital St. Louis, Paris, France.
  • Deconinck E; Hospital Clinic, Barcelona, Spain.
  • Damaj G; Hopital Jean Minjoz, Besancon, France.
  • Maury S; Centre Hospitalier-Universitaire, Institut d'Hématologie, Normandie University, Caen, France.
  • Beelen D; Service d'Hématologie Clinique et de Thérapie Cellulaire Creteil, CHU Henri Mondor, Créteil, France.
  • Quoc SN; University Hospital, Essen, Germany.
  • Shankara P; Hopital la Pitié-Salpêtrière, Universite Paris IV, Paris, France.
  • Brecht A; Birmingham Heartlands Hospital, Birmingham, UK.
  • Mayer J; Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany.
  • Hunault-Berger M; University Hospital Brno, Brno, Czech Republic.
  • Bittenbring J; Maladies du Sang, CHU Angers, Angers, France.
  • Thieblemont C; University of Saarland, Homburg, Saar, Germany.
  • Lepretre S; Hôpital St. Louis, Paris, France.
  • Baldauf H; Inserm U1245 and Department of Hematology, Centre Henri Becquerel, Normandie University, Rouen, France.
  • de Wreede LC; DKMS, Dresden, Germany.
  • Tournilhac O; Department of Medical Statistics & Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.
  • Yakoub-Agha I; Service Therapie Cellulaire & Hematologie Cliniquer, Centre Hospitalier Universitaire, Clermont Ferrand, France.
  • Kröger N; Centre Hospitalier Universitaire de Lille, LIRIC, INSERM U995, Université de Lille, Lille, France.
  • Dreger P; University Hospital Eppendorf, Hamburg, Germany.
Bone Marrow Transplant ; 57(2): 330, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34773088
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article